Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors. (Q42639909)
Jump to navigation
Jump to search
scientific article published on January 2008
Language | Label | Description | Also known as |
---|---|---|---|
English | Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors. |
scientific article published on January 2008 |
Statements
Antisense therapeutics for tumor treatment: the TGF-beta2 inhibitor AP 12009 in clinical development against malignant tumors (English)
K H Schlingensiepen
B Fischer-Blass
S Schmaus